Recently, suppressor T lymphocytes have been associated with reduced in vitro T cell functions in several neoplastic diseases in humans such as thymoma, multiple myeloma, Hodgkin's disease and other malignancies (Broder & Waldmann, 1978; Naor, 1979; Yu et al., 1977; Hersh et al., 1980) . Concanavalin A (Con A) has been extensively used as an in vitro stimulus for the generation of suppressor cells and soluble suppressor factors (Shou et al., 1976) to elucidate the suppressor phenomenon in cancer (Catalona et al., 1980; Toge et al., 1980; Uchida & Micksche, 1981; Shulof et al., 1980; Yu et al., 1977) .
In our earlier studies we demonstrated that lymphocytes from chronic myeloid leukaemia (CML) patients in remission react to leukaemiaassociated antogens in vitro (Gangal et al., 1976 (Gangal et al., , 1979 Khare et al., 1981) . When a small group of patients was followed up through 2nd and 3rd cycles of relapse and remission, it was observed that leukaemia associated in vitro immune reactivity was negatively correlated with the progress of the disease (Gangal et al., 1977) . It was felt that the possible progressive inability of lymphocytes from CML patients to respond to leukaemia-associated antigens as the disease advanced, could be due to increased suppressor cell activity. Therefore, in the present paper we have attempted to assess the generation of suppressor cell activity by Con A in the peripheral blood of CML patients in first and subsequent remissions. Suppressor cell activity has been tested by the ability of Con A activated lymphocytes to inhibit PHA response of autologous lymphocytes, in comparison with similarly treated lymphocytes obtained from normal healthy individuals.
It is know that Con A is capable of inducing both helper and suppressor populations depending upon the dose of mitogen used. Sakane et al. (1981, 1982) (generally >90%) and suspended at a concentration of 2 x 106 viable cells ml'-in complete medium.
Responder cells stored at 4°C were washed twice with complete medium and suspended in complete medium adjusting the cell count to 2 x 106 viable cells ml-'. Quadruplicate cultures were set up in microtiter plates with 0.1 ml responders, 0.1 ml regulators (treated with or without Con A) and 10pgml-' of PHA (Difco). The 1:1 ratio of responders to suppressor was deduced after ascertaining the maximum suppressor activity of suppressor cells added at 2:1, 1:1 and 1:2 ratios. This ratio of responders and suppressors has also been used by several other investigators (Catalona et al., 1980; Sakane et al., 1981; Toge et al., 1980; Uchida & Micksche, 1981) . In one set of cultures responder cells alone were stimulated with PHA to obtain maximum response. In each set, control cultures were kept without addition of PHA. Proliferative response was evaluated after 72h by addition of 0.5 pCi/well of [3H]-dT (Sp. act. 5-9CimM-', BARC, Trombay, Bombay, India) 16-18h prior to harvesting. Cultures were processed for scintillation counting as described earlier (Gangal et al., 1979) . The results are expressed as net cpm wherein mean cpm of unstimulated cultures is subtracted from cpm of each stimulated culture. Percentage suppression was calculated using the following formula: % Suppression= 100
Net cpm in responders + regulators + PHAt Net cpm in responders + PHA J The results were analysed by Student's t test.
Enumeration of autologous rosette forming cells (ARFC) Peripheral blood mononuclear cells from CML patients in remission and normal healthy controls were separated and incubated with or without Con A as before. However, for generation of ARFC, instead of terminating the Con A treatment after 24 h, the treatment was continued up to 60 h (Sakane et al., 1981) . At the end of the incubation period, cells were washed with 0.85% saline containing 0.3 Ma-methyl glucoside to remove Con A as before. Cell concentration was then adjusted to 2x 106 cells in 0.2ml of RPMI 1640 and 0.3ml of FCS. To this, 0.5 ml of 1% autologous RBCs suspended in RPMI 1640 were added. For obtaining autologous RBCs peripheral blood of the same individual was collected separately in Alsever's solution on the first day, washed and stored in Alsever's solution at 4°C. Before use, the RBCs were washed 5 times with 0.85% saline and suspended in RPMI 1640. The Con A treated and untreated cells were mixed with autologous RBCs thoroughly, incubated at 37°C for 20-30min, centrifuged at low speed and kept at 4°C overnight. The next day, the pellet was gently shaken, a drop of methylene blue was added to stain the lymphocytes and a total of 200 lymphocytes (rosetted and nonrosetted) were counted to enumerate the percentage of ARFC. (Table III) showed suppressor activity similar to those in the 1st remission. In the 10 cases reported in Table III , Con A induced suppression varied between 50.6% and 79.7%. The spontaneous suppression was also similar to that seen in the lymphocytes from CML patients in 1st remission (25.3%). Only 5 CML patients in 3rd remission could be investigated for induction of suppressor cell activity (Table IV) . Although the Con A induced suppression was slightly reduced (55.3%), it appears that the generation of spontaneous suppressor cells is much lower in CML patients in 3rd remission (14.5%), than the previous groups (1st and 2nd remissions).
Results
Table V summarises the data on Con A induced and spontaneous suppressor cell activity as well as ARFC in CML patients in 1st, 2nd and 3rd remission in comparison with normal healthy individuals. As stated earlier, all the remission patients, irrespective of the progression of the disease had comparable Con A induced suppressor cell activity, which was significantly higher than the controls. Activation of spontaneous suppressor cells by mere incubation of lymphocytes in in vitro condition, was also higher in CML patients in 1st and 2nd remission than controls, while spontaneous suppression seemed to be reduced in CML patients in 3rd remission. On the other hand, Con A induced autorosette forming cells were significantly higher than controls in CML patients in 1st remission only, whereas CML patients in 2nd and 3rd remission showed normal percentage of ARFC. The lack of correlation between ARFC activity and suppressor cell function in 2nd and 3rd remission lymphocytes samples however, cannot be firmly concluded since only a few independent blood samples have been tested for ARFC. There was no spontaneous increase in ARFC in normal subjects or any of the CML remission patients.
Discussion
Presence of suppressor cells in hosts bearing tumours, capable of inhibiting antitumour immune responses in vitro has often been demonstrated in human systems (Broder & Waldmann 1978; Naor 1979; Yu et al., 1977; Hersh et al., 1980; Toge et al., 1980 and Uchida & Micksche, 1981) . In the present investigation we have tried to evaluate the presence of precursors of suppressor cells in CML patients in (Shou et al., 1976; Tsokos & Balow, 1982; Sakane & Green 1977; Catalona et al., 1979; Uchida & Micksche 1981; Shulof et al., 1980; Toge et al., 1980) . Catalona et al (1979) (1980) . Similarly, our data also show that most of the CML patients in remission had normal blastogenic responses to PHA, yet they showed a significantly increased generation of suppressor cell population, unlike that reported by Hersh et al. (1980) . In this study, two patients, viz. AP 1263 and AN 16907 were tested sequentially in 1st and 2nd remissions. It is interesting to note that AN 16907 showed 57% suppression of PHA response of autologous lymphocytes in presence of Con A activated cells in the 1st remission, which was increased to 79.7% (P<0.001) in the 2nd remission.
Similarly, in the 1st remission he showed spontaneous suppression to the extent of 26.1%, which was increased to 45.4% (P<0.001) in the 2nd remission. Unfortunately, this patient was lost to follow up thereafter so that progression of his disease cannot be correlated with these findings. On the other hand, patient AP 1263 did not show a difference in Con A induced suppressor cell activity in 1st and 2nd remission, although he showed increased spontaneous suppresion in 2nd remission. This patient continued to be in remission for -8 months, and has now entered into relapse.
In our experiments, spontaneous differentiation of lymphocytes into functional suppressors, after incubation in tissue culture media for 24h was seen in healthy donors as well as in CML patients. However, a signifiantly higher degree of spontaneous suppression was seen in lymphocytes from CML patients than from healthy donors. Spontaneous generation of suppressor cells has been shown to occur by other investigators (Burns et al., 1975; Gattringer et al., 1981; Tsokos & Balow, 1982) . It was surprising to note that in our experiments patients in the 3rd remission, who are closer to the terminal stage of the disease, showed spontaneous suppression comparable to normal donors. From these data it appears that the presence of a suppressor cell precursor subset of T cells in the circulation perhaps does not influence the course of the disease in CML.
The phenomenon of autorosette formation has not received much attention to date. Our data suggest that Con A activated cells show increased autorosette formation, as has been demonstrated by Sakane et al. (1981 Sakane et al. ( , 1982 ). It appears that CML patients in 1st remission had significantly higher ARFC after Con A treatment. However, in a few patients tested in subsequent remissions, ARFC seem to be comparable to controls. In an independent group of CML patients in 2nd and 3rd remission, functionally suppressive cells could be demonstrated. This lack of correlation between the two assays needs to be confirmed in a larger number of pateints. Spontaneous generation of ARFC was not demonstrable either in healthy donors or in CML patients.
